Advantages of Biocytogen's BsAb Platform
- Versatile Design: Enables the assembly of diverse components like scFv, peptides, VHHs, and cytokines with flexible formats supported by technologies like Knobs-into-Holes.
- Common Light Chain Advantage: Produces fully human common light chain antibodies for efficient and precise bispecific assembly with minimal mispairing.
- High-Quality Antibodies: Combines RenLite KO mice and Beacon technology to generate antibodies with exceptional diversity and affinity.
- Scalable Validation: Employs a robust in vivo system to identify effective and safe target combinations.
- Bifunctional Molecules: Develops antibody-cytokine molecules with superior synergy, enhancing the druggability of cytokine-based therapies.
Biocytogen's RenLite-based BsAb Platform
BsAb developed from RenLite mice
Off-the-shelf BsAbs Available for Partnership
